Myopia Control in Children: Comparison of Defocus Incorporated Multiple Segments® Lenses Versus Atropine 0.05% Eyedrops
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
Myopia is the most common refractive disorder in the world. Many strategies have been
developed to control myopia in children. Among them, the instillation of low-concentration
atropine eyedrops has been proven to be effective in numerous publications. Nevertheless, the
spreading of atropine use is limited by: (1) its uneven availability, (2) a proportion of
children with no or poor response, (3) some issues of long-term compliance (4) the
possibility of a rebound effect after treatment cessation.
Among the non-drug myopia control strategies, corrective lenses including the Defocus
Incorporated Multiple Segments® (DIMS®) technology have demonstrated their effectiveness in a
previous study (Hong Kong) when compared to monofocal lenses.
The aim of this study is to compare the efficacy of DIMS lenses alone versus atropine 0.05%
eyedrops + monofocal lenses, on the evolution of ocular axial length at 2 years in myopic
children.